35 patients (47.9%) developed AKI during colistin use, 60% at the first week and 40% at the second week; 31.4% of AKI cases was classified as stage 1 (AKIN staging system), 25.8% as stage 2 and 42.8% as stage 3; 28.6% of AKI cases needed renal replacement therapy.